Fig. 1
From: Sex-based clinical and immunological differences in COVID-19
Survival analysis and comparison of prognostic related indicators between males and females from the first to 11th week after symptom onset. A Sex-based survival analysis of COVID-19 patients. B-E Differences of laboratory findings in male and female patients. Red represents female patients, and blue represents male patients. The x-axis displays weeks after symptom onset. The y-axis displays the level of indicators or percentage of patients with abnormal indicators. The line chart shows the mean and standard deviation of indicator values, and the significance is calculated by the Wilcoxon test. The Fisher test calculates the significance in the histogram. The number of patients per week after symptom onset is shown in the graph. *, P < 0.05; **, P < 0.01; ***, P < 0.001